Greetings from Graz, Austria! The part of our team is these days participating in HTH Styria Pitch & Partner event #HTHStyria. Cardiolyse has been selected out of 70+ companies to present our solution on 2 corporate challenges out of 4 organized by the event hosts. It’s been two insightful days of great inspiration, deep and productive networking, as well as […]

A year of new achievements and new happiness started just perfectly with Cardiolyse finally receiving its CE and ISO certification papers! We’re certified as a standalone software medical device for automatic ECG interpretation, which now fully opens all the doors for sustainable commercial partnerships with hospitals, pharmacies, GP networks, and other digital health market disruptive players. Within the certification process, […]

One of Cardiolyse product core technologies for the unique Method of ECG Evaluation to deliver personalized cardiac risk assessment has been issued with the US patent! The patent covers the invention of the Universal ECG Score, which is designed to diagnose the cardiovascular system based on at least 148 quantitative ECG parameters rating and aggregation. The score calculated provides the […]